The headline reads as positive (76% confidence from the FinBERT financial-language model), so the stock went through the full analysis. The broader analysis agrees with the good news.
Stocks › CMPS
COMPASS Pathways Plc - American (CMPS) stock analysis
SKIP 11% confidence · analysed Oct 14, 2026
On Oct 14, 2026, our model rated COMPASS Pathways Plc - American (CMPS) SKIP with 11% confidence at a price of $11.14. That means the signals cancel out; the model sees no clear edge either way.
SectorHealthcare
IndustryMedical Care Facilities
Market cap1.54B
Analysed price$11.14
Technical picture
The 14-day RSI is 19, below 30, which is oversold territory: sellers have pushed hard recently. Oversold stocks often bounce, but they can stay weak for a while.
MACD is below its signal line, so short-term momentum is pointing down.
The price has slipped below its 50-day moving average but is still above the 200-day: a pullback inside a longer-term uptrend.
Volume is only 0.7x its 20-day average; light trading makes the latest move less convincing.
Fundamentals
The company reports a profit margin of 0.0%.
In its latest quarter it earned $-0.36 per share, which missed the $-0.33 analysts expected.
Wall Street's average rating is 1.3 on a 1 (strong buy) to 5 (sell) scale, roughly a "strong buy", with an average price target of $23.75.
The next earnings report is expected around Nov 3, 2026; prices often move sharply around earnings.
The model's one-paragraph read
No clear edge (SKIP) — composite score -0.11 (SKIP). Technicals: RSI 19.44, MACD bearish, price below SMA50. Fundamentals: margin 0.0%. Financial results: last EPS surprise -9.1%, next earnings 2026-11-03. FinGPT news read: positive. Memory: 1 prior look(s). Reference price $11.27; no trade levels (SKIP).
Past ratings for CMPS
| Date | Verdict | Confidence | Price | Move since | |
|---|---|---|---|---|---|
| Oct 14, 2026 | SKIP | 11% | $11.14 | — |
"Move since" compares each call's price with the latest analysed price.
Recent news on CMPS
Oct 14, 2026 · Compass Pathways Joins Forces with Leading Mental Health Organizations to Mark First-Ever U.S. Treatment-Resistant Depression (TRD) Awareness Day
- Oct 14, 2026: Compass Pathways Joins Forces with Leading Mental Health Organizations to Mark First-Ever U.S. Treatment-Resistant Depression (TRD) Awareness Day (Business Wire)
Other Healthcare stocks we cover
CNC · COO · CRL · CVS · CYTK · DVA · ETON · EVH · FTRE · HALO · HUM · IART
Frequently asked questions
Is CMPS a buy right now?
As of Oct 14, 2026, our automated model rates COMPASS Pathways Plc - American (CMPS) SKIP with 11% confidence: the signals cancel out; the model sees no clear edge either way. This is a model output for education, not personal investment advice.
When does COMPASS Pathways Plc - American report earnings next?
The next earnings report is expected around Nov 3, 2026.
What does a SKIP rating mean?
A SKIP rating means the signals cancel out; the model sees no clear edge either way.
For information and education only. Not investment advice. Ratings are produced by an automated model, can be wrong, and may be out of date. Do your own research; you can lose money investing. The site's author may hold positions in stocks discussed here.